In vitro resistance to cytosine arabinoside, not to daunorubicin, is associated with the risk of relapse in de novo acute myeloid leukaemia

British Journal of Haematology

Volumn 93, Issue 4, 1996, Pages 903-910

  Klumper, Edwin ^a   Ossenkoppele, Gert J ^a   Pieters, Rob ^a   Huismans, Dieuwke R ^a   Loonen, Annemarie H ^a   Rottier, Antoinette ^a   Westra, Guus ^a   Veerman, Anjo J P ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

chemosensitivity; cytotoxicity; drug resistance; MTT assay; myeloid leukaemia

Indexed keywords

AMSACRINE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; DRUG RESISTANCE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0029971156     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1742.x     Document Type: Article

References (27)

1. Arceci, R.J. (1993) Clinical significance of P-glycoprotein in multi-drug resistance malignancies. Blood, 81, 2215-2222.
2. Delmer, A., Marie, J-P., Thevenin, D., Cadiou, M., Viguie, F. & Zittoun, R. (1989) Multivariate analysis of prognostic factors in acute myeloid leukemia: value of clonogenic leukemic cell properties. Journal of Clinical Oncology, 7, 738-746.
3. Geller, R.B. & Larson, R.A. (1991) Therapy for acute myeloid leukaemia and acute lymphoblastic leukaemia in adults. Current Opinion in Oncology, 3, 30-38.
4. Griffin, J.D. & Löwenberg, B. (1986) Clonogenic cells in acute myeloblastic leukemia. Blood, 68, 1185-1195.
5. Harousseau, J.L., Milpied, N., Briere, J., Desablens, B., Leprise, P.Y., Ifrah, N., Gandhour, B. & Casassus, P. (1991) Double intensive consolidation chemotherapy in adult acute myeloid leukemia. Journal of Clinical Oncology, 9, 1432-1437.
6. Lee, E.J., Yang, J., Leavitt, R.D., Testa, J.R., Civin, C.I., Forrest, A. & Schiffer, C.A. (1992) The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia. Leukemia, 6, 1203-1209.
7. Mayer, R.J. (1990) Acute leukemias in adults: an overview of recent strategies. Journal of Cancer Research and Clinical Oncology, 116, 94-96.
8. Mayer, R.J., Davis, R.B., Schiffer, C.A., Berg, D.T., Powell, B.L., Schulman, P., Omura, G.A., Moore, J.O., McIntyre, O.R. & Frei, E., III (1994) Intensive postremission chemotherapy in adults with acute myeloid leukemia. New England Journal of Medicine, 331, 896-903.
9. Miyauchi, J., Kelleher, C.A., Wang, C., Minkin, S. & McCulloch, E.A. (1989) Growth factors influence the sensitivity of leukemic stem cells to cytosine arabinoside in culture. Blood, 73, 1272-1278.
10. Phillips, G.L., Reece, D.E., Shepherd, J.D., Barnett, M.J., Brown, R.A., Frei-Lahr, D.A., Klingemann, H.G., Bolwell, B.J., Spinelli, J.J., Herzig, R.H. & Herzig, G.P. (1991) High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adults. Blood, 77, 1429-1435.
11. Pieters, R., Huismans, D.R., Loonen, A.H., Hählen, K., van der Doesvan den Berg, A., van Wering, E.R. & Veerman, A.J.P. (1991) Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia. Lancet, 338, 399-403.
12. Pieters, R., Loonen, A.H., Huismans, D.R., Broekema, G.J., Dirven, M.W.J., Heyenbrok, M.W., Hählen, K. & Veerman, A.J.P. (1990) In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions. Blood, 76, 2327-2336.
13. Pirker, R., Wallner, J., Geissler, K., Linkesch, W., Haas, O.A., Bettelheim, P., Hopfner, M., Scherrer, R., Valent, P., Havelec, L., Ludwig, H. & Lechner, K. (1991) MDR1 gene expression and treatment outcome in acute myeloid leukemia. Journal of the National Cancer Institute, 83, 708-712.
14. Pommier, Y. (1993) DNA topoisomerase I and II in cancer chemotherapy: update and perspectives. Cancer Chemotherapy and Pharmacology, 32, 103-108.
15. Preisler, H., Raza, A., Larson, R., Goldberg, J., Tricot, G., Carey, M. & Kukla, C. (1991) Some reasons for the lack of progress in the treatment of acute myelogenous leukemia: a review of three consecutive trials of the treatment of poor prognosis patients. Leukemia Research, 15, 773-780.
16. Salmon, S.E. (1990) Chemosensitivity testing: another chapter. Journal of the National Cancer Institute, 82, 32-33.
17. Salmon, S.E., Alberts, D.S., Meyskens, F.L., Durie, B.G.M., Jones, S.E., Soehnlen, B., Young, L., Chen, H.S.G. & Moon, T.E. (1980) Clinical correlations of in vitro drug sensitivity. Cloning of Human Tumor Stem Cells (ed. by S. E. Salmon), pp. 223-245. Liss, New York.
18. Santini, V., Bernabei, P.A., Silvestro, L., Dal Pozzo, O., Bezzini, R., Viano, I., Gattei, V., Saccardi, R. & Rossi Ferrini, P. (1989) In vitro chemosensitivity testing of leukemic cells: prediction of response to chemotherapy in patients with acute non-lymphocytic leukemia. Hematological Oncology, 7, 287-293.
19. Sargent, J.M. & Taylor, C.G. (1989) Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia. British Journal of Cancer, 60, 206-210.
20. Schiller, G.J., Nimer, S.D., Territo, M.C., Ho, W.G., Champlin, R.E. & Gajewski, J.L. (1992) Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukaemia in first remission. Journal of Clinical Oncology, 10, 41-46.
21. te Boekhorst, P.A.W., Löwenberg, B. & Sonneveld, P. (1993b) Enhanced chemosensitivity in acute myeloid leukemia by hematopoietic growth factors: a comparison of the MTT assay with a clonogenic assay. Leukemia, 7, 1637-1644.
22. te Boekhorst, P.A.W., de Leeuw, K., Schoester, M., Wittebol, S., Nooter, K., Hagemeijer, A., Löwenberg, B. & Sonneveld, P. (1993a) Predominance of functional multidrug resistance (MDR-1) phenotype in CD34′ acute myeloid leukemia cells. Blood, 82, 3157-3162.
23. Tidefelt, U., Sundman-Engberg, B., Rhedin, A-S. & Paul, C. (1989) In vitro drug testing in patients with acute leukaemia with incubations mimicking in vivo intracellular drug concentrations. European Journal of Haematology, 43, 374-384.
24. Veerman, A.J.P. & Pieters, R. (1990) Drug sensitivity assays in leukaemia and lymphoma. British Journal of Haematology, 74, 381-384.
25. Von Hoff, D.D. (1990) He's not going to talk about in vitro predictive assays again, is he? Journal of the National Cancer Institute, 82, 96-101.
26. Weisenthal, L.M. (1993) Cell culture drug resistance assays in hematologic neoplasms based on the concept of total tumor cell kill. Drug Resistance in Leukemia and Lymphoma (ed. by G. J. L. Kaspers, R. Pieters, P. R. Twentyman, L. M. Weisenthal and A. J. P. Veerman), pp. 415-432. Harwood Academic Publishers, Chur, Switzerland.
27. Willemze, R., Fibbe, W.E., Kluin-Nelemans, J.C., Falkenburg, J.H.F. Richel, D.J., Peters, W.G., den Ottolander, G.J., Brand, A. & Zwaan, F.E. (1991) Bone marrow transplantation or chemotherapy as post-remission treatment of adult acute myelogenous leukemia. Annals of Hematology 62, 59-63.